Steven F. Bellon - Jan 26, 2023 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Scientific Officer
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Jan 26, 2023
Transactions value $
$0
Form type
4
Date filed
1/30/2023, 04:03 PM
Previous filing
Aug 15, 2022
Next filing
Jan 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $0 +100K $0.00 100K Jan 26, 2023 Common Stock 100K $8.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.